Consistent with the correlations between mutations activating PI3K signaling and TBX2 in human and mouse tumors, TBX2 protein levels were decreased in three human melanoma cell lines using two different PI3K inhibitors: LY294002 or GDC0941 (Fig. 1H). The gene discussed is TBX2; the disease is melanoma.